Chemoinformaics analysis of Cpfnikyedjfrat-ypovqpidsa-
| Molecular Weight | 550.689 | nRot | 4 |
| Heavy Atom Molecular Weight | 504.321 | nRig | 31 |
| Exact Molecular Weight | 550.314 | nRing | 6 |
| Solubility: LogS | -3.778 | nHRing | 2 |
| Solubility: LogP | 3.337 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 85 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 39 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
| nHA | 9 | APOL | 87.9905 |
| nHD | 4 | BPOL | 53.9595 |
| QED | 0.358 |
| Synth | 5.389 |
| Natural Product Likeliness | 2.663 |
| NR-PPAR-gamma | 0.79 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.023 |
| Pgp-sub | 0.998 |
| HIA | 0.87 |
| CACO-2 | -5.921 |
| MDCK | 0.0000216 |
| BBB | 0.095 |
| PPB | 0.92383 |
| VDSS | 0.695 |
| FU | 0.083805 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.876 |
| CYP2c19-inh | 0.007 |
| CYP2c19-sub | 0.548 |
| CYP2c9-inh | 0.037 |
| CYP2c9-sub | 0.06 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.14 |
| CYP3a4-inh | 0.381 |
| CYP3a4-sub | 0.168 |
| CL | 3.119 |
| T12 | 0.303 |
| hERG | 0.499 |
| Ames | 0.03 |
| ROA | 0.754 |
| SkinSen | 0.832 |
| Carcinogencity | 0.18 |
| EI | 0.011 |
| Respiratory | 0.967 |
| NR-Aromatase | 0.845 |
| Antiviral | Yes |
| Prediction | 0.615437 |